Write in a clean editor, then format for Journal of Cutaneous Immunology and Allergy in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Cutaneous Immunology and Allergy is a peer-reviewed journal published by Frontiers, covering Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Urticaria and Related Conditions. Over its lifetime it has published 455 papers, which have received 715 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Journal of Cutaneous Immunology and Allergy. 2023;12(3):45–58.
Formats any DOI in Journal of Cutaneous Immunology and Allergy style. No sign-up. |
| Publishes research in | Dermatology and Skin Diseases Autoimmune Bullous Skin Diseases Urticaria and Related Conditions Cutaneous lymphoproliferative disorders research Allergic Rhinitis and Sensitization |
| ISSN | 2574-4593 |
| Citation impact (2-yr) | 0.78 |
| h-index | 10 |
| i10-index | 12 |
| Article processing charge | $2,420 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | The University of Osaka |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Atopic dermatitis ( AD ) and psoriasis (Pso) are two common inflammatory skin diseases which are symptomatically characterized by pruritus to variable degrees. Whereas AD is nearly always associated with pruritus, only 50%‐70% of patients with Pso suffer from itching. Within the last decade, the development of biologic agents targeting specific cytokines or cytokine…
Abstract T helper 1 (Th1) and T helper 2 (Th2) populations are a classical dichotomy to understand the immunological disorders, and this concept remains vital in atopic dermatitis ( AD ). While IL ‐4 and IL ‐13 are produced mainly by Th2 cells, mast cells, and basophils, these cytokines target these producers, indicating the presence…
Dear Editor, Apalutamide, a novel nonsteroidal antiandrogen agent, is used for the treatment of castration-resistant prostate cancer. Although skin rash is a common side effect of apalutamide, toxic epidermal necrolysis (TEN) has not been reported yet. Here, we report a case of apalutamide-associated TEN. A 77-year-old male patient received apalutamide (240 mg/day) for the treatment…
Abstract Drugs are one of the representative exogenous agents that cause photosensitive dermatitis. Both phototoxic and photoallergic mechanisms exist in photosensitivity to exogenous agents. While the phototoxic reaction is mediated mainly by reactive oxygen species, the photoallergic reaction is induced and elicited by immunological consequences. Two hypotheses have been put forward to explain the formation…
Abstract Background Since the campaign of vaccination against COVID‐19 was started, a wide variety of cutaneous adverse effects after vaccination has been documented worldwide. Varicella zoster virus (VZV) reactivation was reportedly the most frequent cutaneous reaction in men after administration of mRNA COVID‐19 vaccines, especially BNT162b2. Aims A patient, who had persistent skin lesions after…
